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Abstract. Two high-affinity mAbs were prepared 
against Torpedo dystrophin,  an electric organ protein 
that is closely similar to human dystrophin, the gene 
product of the Duchenne muscular dystrophy locus. 
The antibodies were used to localize dystrophin rela- 
tive to acetylcholine receptors (AChR) in electric or- 
gan and in skeletal muscle, and to show identity be- 
tween Torpedo dystrophin and the previously described 
270/300-kD Torpedo postsynaptic protein.  Dystrophin 
was found in both AChR-rich and AChR-poor regions 
of the innervated face of the electroplaque. Immuno- 
gold experiments showed that AChR and dystrophin 
were closely intermingled  in the AChR domains.  In 
contrast,  dystrophin appeared to be absent from many 
or all AChR-rich domains of the rat neuromuscular 
junction and of AChR clusters in cultured muscle (Xeno- 
pus laevis). It was present,  however, in the immedi- 
ately surrounding membrane (deep regions of the junc- 
tional folds, membrane domains interdigitating  with 
and surrounding AChR domains within clusters). These 
results suggest that dystrophin may have a  role in or- 
ganization of AChR in electric tissue. Dystrophin is 
not, however, an obligatory component of AChR do- 
mains in muscle and,  at the neuromuscular junction, 
its roles may be more related to organization  of the 
junctional folds. 
UCHENNE and Becker muscular dystrophies are dis- 
eases of muscle necrosis and wasting that arise from 
qualitative  and/or quantitative  defects in dystrophin, 
a cytoplasmic protein associated with all regions of the sar- 
colemma in skeletal, cardiac,  and smooth muscle (reviewed 
in Hoffman and Kunkel,  1989; Witkowski,  1989).  Dystro- 
phin was unknown before its discovery by genetic methods, 
and its cell biological activities  have not yet been directly 
demonstrated. However, the deduced amino acid sequence 
shows  that dystrophin  is a member of the spectrin/alpha- 
actinin  family of actin-binding,  triple helix rod-containing 
proteins (Hammonds, 1987; Koenig et al., 1988). The skele- 
tal muscle isoform, with a predicted molecular weight and 
length of 427,000 D and 150 nm (Koenig et al.,  1988), has 
been isolated after detergent solubilization  as a complex of 
several  proteins including  at least one integral  membrane 
protein (Ervasti et al.,  1990). The role of this protein com- 
plex is not yet known, but two hypotheses have been pro- 
posed. By analogy to the role of spectfin in the erythrocyte, 
dystrophin in normal muscle may act to stabilize the plasma 
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membrane against contraction-induced mechanical  damage 
(Mandel,  1989);  mechanical  damage is an early event in 
necrosis of Duchenne muscle ceils (Rowland,  1980; Engel, 
1986). Alternatively,  dystrophin  may be involved in regula- 
tion of Ca2*-permeable leak or stretch-inactivated  channels 
such as that absence of dystrophin entrains the high internal 
[Ca  2÷] and poor calcium regulation  characteristic  of dystro- 
phin-minus muscle (Mongini et al., 1988; Franco and Lans- 
man,  1990; Fong et al.,  1990). 
In mammalian  skeletal  muscle, the neuromuscular junc- 
tion appears to be a site at which dystrophin is particularly 
concentrated, since junctions were very brightly labeled by 
anti-dystrophin  antibodies in several studies  (e.g., Shimizu 
et al.,  1989). In addition,  Fardeau et al. (1990) found that 
antibodies against the NH2-terminal, central rod, and COOH- 
terminal  portions of dystrophin  stained junctions in muscle 
from Duchenne patients and the mdx mouse, a dystrophin- 
minus mutant (Hoffman et al.,  1987; Sicinski et al.,  1989). 
Since the sareolemmae were not stained (confirming the ab- 
sence of  bona fide dystrophin), the cross-reactivity must have 
been due to a distinct but dystrophin-like  protein or proteins. 
Alpha-actinin  and an unusual form ofbeta-spectrin have also 
been detected at the junction (Bloch and Hall,  1983; Block 
and Morrow,  1989). Thus,  evidence exists for the presence 
at the junction of at least four members of the dystrophin/ 
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particular requirements for proteins of this type in molecular 
organization of the cholinergic postsynaptic membrane. The 
nature of these requirements is in general unknown, particu- 
larly with respect to the mature junction. The beta-spectrin 
isoform has, however, been directly implicated in clustering 
of acetylcholine  receptors  (AChR) ~ in  cultured,  aneural 
muscle (Bloch and Morrow,  1989;  Pumplin,  1989). 
Dystrophin or a very similar protein is also a component 
of the postsynaptic membrane in electric tissue of electric 
rays (Torpedo sp.; Chang et al.,  1989; Jasmin et al.,  1990). 
Electric tissue is a highly simplified,  noncontractile tissue 
that derives embryologically from striated muscle (Fox and 
Richardson,  1978); it is well known as a source of several 
proteins  including  AChR  that  have homologues  in  skele- 
tal muscle.  The discovery that it also contains  dystrophin 
should be of great importance for biochemical studies, since 
highly purified postsynaptic membranes are readily prepared 
from electric tissue. In this study, we have used two high- 
affinity mAbs to localize dystrophin relative to domains of 
high AChR density in electric tissue, in mature rat skeletal 
muscle, and in cultured skeletal muscle from Xenopus. The 
aims were to identify possible roles of dystrophin in post- 
synaptic structure and molecular organization and to com- 
pare electric tissue to muscle with regard to these roles. 
Materials and Methods 
Materials 
Electric rays (Narcine brasiliensis,  Torpedo californica,  and T. nobiliana) 
were obtained from Gulf Specimen Co. (Panacea, FL), Pacific BioMarine 
(Venice, CA),  and Bio-Fish, Inc. (Georgetown,  MA), respectively. Munich 
Wistar rats and Xenopus/aev/s were obtained from local breeding colonies. 
Control mice (C57BL/10SnJ)  and mdx mice (C57BL/10ScSn-mdx)  were 
purchased  from Jackson Laboratories (Bar Harbor,  ME).  FITC-alpha- 
bungarotoxin and FITC-labeled,  affinity-purified rabbit anti-bungarotoxin 
were  prepared by conventional procedures  (Anderson and Fambrough, 
1983; Ravdin and Axelrod, 1977). Other fluorescent antibodies ware Affini- 
Pure antibodies from Jackson Immunoresearch Laboratories (West Grove, 
PA).  Rabbit anti-mouse IgG was  prepared locally or was  from Fisher 
Scientific Co. (Springfield,  NJ). Goat anti-rabbit IgG complexed to 10 nm 
colloidal gold was obtained from Energy Beam Sciences (Agawam, MA). 
mAbs 1234A and 264E have been described previously  (Froehner et al., 
1983; Sealock et al., 1984; Peng and Froehner, 1985). Gelatin from the skin 
of cold water fish was from Sigma Chemical Co. (St. Louis, MO; catalog 
number G-7765). 
Production and Characterization of mAbs 
Torpedo AChR-enriched  membranes and peripheral membrane proteins 
therefrom were prepared as previously  described (Porter and Froehner, 
1983).  mAbs  were  IgGls  purified  from  ascites  fluids  on  protein  A 
columns.  Procedures for their preparation and characterization are de- 
scribed in detail in earlier publications (Froehner et al.,  1983; Froehner, 
1984). 
Western Blotting 
Transfer  of proteins to  nitrocellulose (0.45-t~m; Bio-Rad  Laboratories, 
Richmond, CA) was carried out in a cooled Transfor  apparatus 0-loafer 
Scientific Instruments, San Francisco,  CA). For Torpedo proteins, transfer 
was carried out in 114 mM glycine, 25 mM Tris, pH 8.3, for 16 h at an initial 
current of 300 mA or for 2 h at an initial current of 900 mA. In both cases, 
the current increased to 1,200-1,500 mA during the transfer period. For de- 
tection of dystrophin in mouse skeletal  muscle, ,o125 ~tg of microsomal 
1. Abbreviation used in this paper:  AChR,  acetylcholine receptor. 
membranes were run on a 7.5% acrylamide/0.14%  bisacrylamide SDS gel. 
After electrophoresis,  the proteins were transferred to nitrocellulose by 
electrophoresis  in 75 mM glycine,  20 mM Tris, pH 8.4, at 70 V for 6 h 
in the cold. Other methods have been described in detail previously (Froeh- 
ner et al.,  1983; Morton and Froehner, 1989).  Radioiodinated  (Froehner 
et al.,  1983) and alkaline phosphatase-conjugated  second antibodies were 
used on blots of Torpedo proteins and skeletal muscle proteins, respectively. 
Immunopurification of Torpedo Dystrophin 
Torpedo nobiliana AChR-rich membranes prepared through the first sucrose 
gradient in the procedure of Porter and Froehner (1983) were suspended to 
2 m~/mi in buffer A (10 mM phosphate, pH 7.4, 5 mM EDTA, 5 mM EGTA, 
150 mM NaCI, 5/zg/ml pepstatin, 5/~g/ml leupeptin,  2.5/~g/ml PMSF, 5 
mM iodoacetate).  Triton X-100 was added to a final concentration of 1%. 
After  20 rain  on ice and centrifugation  for 30 rain at 30,000 g, the supernatant 
was diluted 1:1 with buffer A, then incubated (2°C,  1 h) on a rotating wheel 
with 2 mi Affigel-lO derivatized  with mab 1808 IgG (1 rng IgG/ml of Affi- 
gel). The gel was then poured into a column and washed successively with 
15 ml buffer A containing 1% Triton, 15 ml buffer A containing 1% Triton 
and 1 M NaC1, and 15 mi buffer A. Bound protein was eluted with 0.1 M 
NH4-acetate,  pH 11.5. Fractions (1 ml) were collected  into tubes contain- 
ing 5/d 1 M DTT and 100 microliters  10 M NHa-aeetate,  pH 6.0 to neu- 
tralize the samples.  Proteins in these fractions were precipitated with TCA 
before SDS gel electrophoresis. 
Competition ELISA Assays 
Methods for preparation of biotinylated mAbs and their use in competition 
assays have been described (LaRochelle  and Froehner, 1986). 
Cultured Muscle 
Cells from the myotomal muscle masses of stage 20-22 Xenopus laevis em- 
bryos were cultured according to Peng and Nakajima (1978) but on cover- 
slips treated with Alscian Blue (10 mg/rnl for 10 rain). The cells were grown 
at 10°C (Anderson, 1986). 
Immunoelectron Microscopy 
Anesthetized electric  rays (Narcine)  were fixed by perfusion (Froehner et 
al.,  1987). Fragments of the fixed tissue were prepared and labeled as de- 
scribed previously  (Wray and Sealock,  1984; Froehner et al., 1987) except 
that mAbs and rabbit anti-mouse IgG were followed by 10 nm colloidal gold 
complexed to goat anti-rabbit IgG. The labeling buffer was Ringer contain- 
ing 0.8% BSA-1.0% fish gelatin or 0.8% BSA-5% normal goat serum-0.1% 
fish gelatin. 
Open membrane fragments were prepared from frozen electric tissue (Z 
californica) by homogenization in the presence of zinc ion as described pre- 
viously (Sealock et al., 1984). They were labeled by the mieroculture well 
method (Wray and Sealock,  1984) using the immunogold method described 
above plus alpha-bungarotoxin and afffinity-purified rabbit anti-bungaro- 
toxin in double-label experiments,  with PBS-0.8% BSA-L0  % fish gelatin as 
buffer. 
All mAbs were used over a concentration range (15-1,000 nM). To con- 
trol for nonspecific  binding, mAbs were replaced  by commercial pooled 
mouse IgG. 
Immunofluorescence 
Unfixed mouse diaphragms and fixed electric tissue (see above) were pre- 
pared for cryostat sections (6/zm) and subjected to double-label immuno- 
fluorescence  by standard methods.  Control experiments  established that 
cross-reactivity  among antibodies used was negligible.  Sections of electric 
tissue (Fig. 5, A, A') were photographed with Kodak Technical Pan devel- 
oped in Kodak HC110. 
Muscle cell cultures  were labeled with FITC-alpha-bungarotoxin,  then 
fixed in ice-cold ethanol. They were then labeled by standard methods with 
rnAb 1958 followed by rhodamine-conjngated goat anti-mouse IgG plus 
FITC-bungarotoxin,  with PBS containing 0.8% BSA and 1% fish gelatin as 
buffer. 
High resolution immunnfiuorescent  localization of mAb binding sites in 
muscle tissue was  done on the flexor  digitorum longus of 4-8-wk-old 
Munich Wistar rats. Dissected muscles were fixed in 1% paraformaldehyde 
in PBS. During fixation (30--45 rain), small bundles of muscle fibers joined 
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terior of bundles was encouraged  by longitudinal cuts through the endplate 
zones. Even with this precaution, labeling intensity in the interior was al- 
ways considerably lower than on the bundle surfaces. Groups of bundles 
were permeabilized  with  0.5% Triton  X-100 and treated with 0.2 M NI-L,CI 
in PBS. 
For labeling, the bundles were incubated with FiTC-alpha-bungarotoxin 
and test antibody  (mAb  1808, mAb 1958, mAb 1234, or pooled  mouse  IgG) 
followed by combined FITC-conjugated  rabbit anti-toxin and rhodamine- 
conjugated goat anti-mouse IgG. After a final wash, the labeled samples 
were fixed in 4% paraformaldehyde  and wafer  embedded in Epon 812 be- 
tween sheets of Aclar film (Kingsley  and Cole, 1988). Endplates zones  (lo- 
cated in the polymerized wafers by fluorescence using a 10× lens) were 
glued to a blank block for sectioning parallel to the surface of the wafer. 
Sections were  0.2-0.4 #m thick, the smallest  value  practicable  given  the in- 
tensity of fluorescein  labeling  achieved  in this procedure. To provide  access 
to the fluorophores for anti-photobleaching  agents (essential for photogra- 
phy of such thin sections), the sections  were  put on slides, treated with Na- 
methoxide/toluene  to remove  the Epon  (Mayor  et al., 1961), passed  into wa- 
ter, and mounted in glycerol  containing N-propyl  gallate (Giloh  and Sedat, 
1982) without being allowed  to dry. They  were  photographed  with a 63×, 
NA 1.3 Planapo  lens (Zeiss)  on Kodak  T-Max  film  ~leveloped  in Diafine  (ex- 
posure index ,v3,200). Exposure times were typically 10-30 s for rhoda- 
mine and 60-90 s for fluorescein. 
Results 
Anti-dystrophin mAbs 
mAbs 1808 and 1958 were developed from mice immunized 
with peripheral membrane proteins extracted from Torpedo 
postsynaptic membranes (see Materials and Methods).  On 
Western blot analysis of the intact membranes (seen in Coo- 
massie blue staining in Fig.  1 A), both mAbs recognized a 
single protein having a relative molecular mass of •  300,000 
(Fig. 1, B and C). The mAbs are directed against distinct epi- 
topes, since they did not compete for binding sites in solid 
phase competition assays (LaRochelle and Froehner,  1986; 
data not shown). A protein at Mr ~300,000 was also recog- 
nized by two sheep antisera against distinct fusion proteins 
of mouse dystrophin (Hoff-man  et al., 1987). One of  these an- 
tisera (anti-60 kD, Fig.  1 E) gave a much stronger reaction 
than the other (anti-30 kD, Fig.  1 F), but both appeared to 
be specific since normal sheep antiserum showed no reactiv- 
ity (Fig. 1 G). The mAbs and the anti-60-kD antiserum also 
stained Western blots of the material immunopurified from 
detergent-solubilized membranes using mAb 1808  (Fig. 2, 
A, B, C, and E). All three of these antibodies therefore rec- 
ognize the same Torpedo protein. 
Both  mAbs also  recognize  mammalian skeletal  muscle 
dystrophin. Dystrophin was located on Western blots of mi- 
crosomal membranes from mouse muscle by staining with 
the anti-60-kD antiserum (Fig. 3 A, lane 2). It consistently 
ran slightly faster than the Torpedo antigen (Fig.  3 A, lane 
1). No specific staining by the antiserum was obtained with 
muscle from mdx mice, a dystrophin-minus mutant (Hoff- 
man et al.,  1987;  Sicinski et al.,  1989).  The same results 
were obtained when the blots were probed with mAbs 1808 
and 1958 (Fig. 3 B, lanes 1-3). When applied to cryostat sec- 
tions of normal mouse diaphragm,  each mAb gave strong 
immunofluorescence staining of the entire sarcolemma, with 
particularly strong staining of  neuromuscular  junctions (iden- 
tiffed with fluorescent alpha-bungarotoxin, Fig. 4, E and H). 
Neither  antibody  stained  sections  of mdx  mouse  muscle 
(Fig. 4, F and I). These are the expected results for anti-dys- 
trophin antibodies, confirmed by staining with the anti-60- 
Figure 1. Western blot analysis of  AChR-rich membranes. Proteins 
of electric organ (Z nobiliana) postsynaptic membranes were sep- 
arated by SDS gel electrophoresis and (A) stained with Coomassie 
blue or transferred to nitrocellulose and incubated with (B) 50 rdVl 
1808 IgG, (C) 50 nM 1958 IgG, (D) 130 nM control mouse IgG, 
(E) anti-60-kD dystrophin serum (diluted 1:500), (F) anti-30-kD 
dystrophin serum (1:500), and (G) control sheep IgG (20 #g/ml). 
The markers on the fight indicate (from the bottom) the position 
of human erythrocyte beta-spectrin  (known molecular weight, 246 
kD; Winkelmann et al., 1990), alpha-spectrin (280 kD; Sahr et al., 
1990), and alpha2-macroglobulin  (358 kD; Sottrup-Jensen et al., 
1984). 
kD antiserum (Fig.  4, A-C).  The mAbs similarly labeled 
normal human muscle, but not Duchenne muscle (data not 
shown). They also gave strong, exclusively sarcolemmal, la- 
beling of skeletal muscle from other species (rat, Xenopus 
/aev/s, and chicken), of cardiac muscle (rat and normal, but 
not mdx, mouse), and of smooth muscle (chicken gizzard) 
(data not shown). These results demonstrate that mAbs 1808 
and 1958 recognize muscle dystrophin, and reinforce the con- 
clusion (Chang et al.,  1989) that electric tissue contains a 
form of dystrophin or a closely related protein. In agreement 
with Chang et al., we call this protein Torpedo dystrophin. 
mAbs 1808 and 1958 appear to be highly specific for dys- 
trophin. They did not stain the interiors of any muscle fibers, 
showing that they do not share cross-reactivities (with the 
C-protein and an isoform of alpha-actinin)  that have been 
identified with other anti-dystrophin antibodies (Yamaguchi 
et al.,  1990; Hoffman et al., 1989). The failure to label Du- 
chenne muscle establishes that they do not cross-react detec- 
tably with human muscle spectrin, which has a normal sar- 
colenunal  distribution  in  Duchenne  muscle (Appleyard et 
al.,  1984).  They also do not recognize  Torpedo  spectrin, 
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sis of normal and mdx mouse 
muscle. Samples in A and B 
were electric organ postsynap- 
tic  membranes (lane 1)  and 
microsomal membranes from 
skeletal  muscle  of  normal  mice 
(lanes 2 and 4) or mdx mice 
(lanes 3  and 5).  Blots in A 
were probed with anti-60-kD 
dystrophin  serum 1:500 (lanes 
1-3) or control sheep serum 
20 t~g/ml  (lanes 4 and 5). In B, 
a mixture of mAbs 1808 and 
1958 (50 nM each) (lanes 1- 
3) or control mouse IgG (100 
nM) (lanes 4 and 5). The non- 
specifically stained band seen 
in all muscle samples is prob- 
ably myosin. 
Figure 2. Western blot analysis of affinity-purified  Torpedo  dystro- 
phin. Dystrophin was purified on a mAb 1808 affinity  column and 
analyzed by SDS gel electrophoresis. (A) Coomassie blue staining. 
The arrowhead indicates the Mr 300,000 protein and the arrow 
points to a protein of •60-kD  present in most preparations. The 
same sample was subjected to Western blot analysis with (B) 50 
nM 1808 IgG, (C) 50 nM 1958 IgG, (D)  130 nM control mouse 
IgG, (E) anti-60-kD  dystrophin serum (1:500) and (F) control 
sheep IgG (20/~g/ml). 
since they do not label the nonirmervated face of the electro- 
plaque (see below). Finally, the failure to label the neuro- 
muscular junction in mdx mice establishes that they do not 
cross-react  with the dystrophin-like protein  identified by 
Fardeau et al. (1990) or the chromosome 6-encoded, dystro- 
phin-related protein (Buckle et al.,  1990;  Khurana et al., 
1990),  which appears to be selectively concentrated at the 
junction  (Froehner,  S.  C.,  and  R.  Sealock,  unpublished 
results). 
Woodruff et al.  (1987)  and Carr et al.  (1989)  have de- 
scribed antibodies against Torpedo proteins at Mr 300,000 
and 270,000,  respectively. These proteins are immunologi- 
cally cross-reactive, and are believed to be the same protein 
(Carr et al., 1989). Antibodies against these proteins (kindly 
furnished by S. Burden [Massachusetts Institute of Technol- 
ogy] and J. B. Cohen [Washington University]) also recog- 
nized immunoattinity  purified Torpedo  dystrophin  on  Western 
blots (data not shown). The 270/300-kD protein is therefore 
Torpedo dystrophin. 
Localization of  Dystrophin in Torpedo 
Postsynaptic Membranes 
Torpedo AChR is not homogeneously distributed within the 
electrogenic call (electroplaque). It is present on the inner- 
vated (postsynaptic) face of  the cell, but absent from the non- 
innervated face (see Sealock and Kavookjian,  1980).  It is 
most densely concentrated in the postsynaptic membrane 
closest to nerve terminals (juxtaneural regions),  and less 
densely concentrated in the deep regions of  the characteristic 
postsynapticinvaginations.  Withinjuxtaneuralregions,  AChR 
is frequently distributed in distinct rows (Heuser and Sal- 
peter, 1979; Hirokawa, 1983). Identification  of any role dys- 
trophin may have in AChR organization thus requires local- 
ization of dystrophin relative to AChR at several different 
levels. 
We localized dystrophin at the tissue level by double-label 
immunofluorescence of cryostat sections  from perfusion- 
fixed electric tissue (N. brasiliensis), rnAbs 1808 and 1958 
labeled only the innervated face (Fig. 5 A'). A similar result 
was obtained by Jasmin et al. (1990) using polyclonal anti- 
bodies.  These results together suggest that the labeling of 
both faces by Chang et al.  (1989)  resulted from a  cross- 
reactivity not revealed by Western blotting. Both juxtaneural 
regions and the postsynaptic invaginations were clearly visi- 
ble in our images (arrowheads in Fig. 5  A').  In contrast, 
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control and mdx mouse diaphragm. Cryo- 
stat sections of normal mouse diaphragm 
(A, B, D, E, G, and H) and mdx mouse di- 
aphragm (C, F,, and I) were labeled with 
anti-60-kD dystrophin antiserum 1:500 (B 
and C), mAb 1808, 50 nM (E and F) and 
mAb 1958, 50 nM (Hand/). Sections from 
normal muscle were double-labeled with 
rhodamine-conjugated alpha-bungarotoxin 
(A, D, and G) to identify AChR. All anti- 
bodies gave very similar labeling of normal 
muscle, but no labeling of mdx muscle. Bar 
(I) 20 t~m. 
strong labeling of the same sections by alpha-bungarotoxin 
and anti-toxin antibodies was confined to the juxtaneural 
regions and the superficial portions of the invaginations (Fig. 
5 A). This agrees with previous visualizations of bungaro- 
toxin binding in the electroplaque (Sealock and Kavookjian, 
1980). In these experiments, we confirmed that this correctly 
represents the AChR distribution, since an mAb against a cy- 
toplasmic epitope  of AChR (mAb  264;  Froehner  et al., 
1983)  gave an image indistinguishable from that given by 
toxin/anti-toxin (data not shown). On the basis of  these data, 
dystrophin appears to be more homogeneously distributed 
over the innervated face than is AChR. 
At the ultrastructural  level  (immunogold experiments), 
rnAbs 1808 and 1958 labeled only the cytoplasmic surface 
of the postsynaptic membrane (Fig. 5 B). In agreement with 
the fluorescence data, background levels  of gold particles 
were  found  on  the  noninnervated  face  (not  shown),  in 
cytoplasm, and on all structures outside the electroplaque 
(see Fig. 5 B). On the postsynaptic membrane, gold particles 
occurred in clumps (arrows in Fig. 5 B) or short continuous 
stretches  (arrowheads).  This  establishes  that juxtaneural 
dystrophin is closely intermingled with AChR,  since jux- 
taneural regions that do not contain AChR at high density 
are extremely rare (Sealock, 1980).  Clusters on the sides of 
invaginations in the deep regions often seemed paired (Fig. 
5 B, arrows), a feature previously noted in labeling of  the 58- 
kD postsynaptic protein (Froehner et al.,  1987).  We found 
little indication of regular patterns  of clusters  like those 
reported in skeletal muscle (Watkins et al., 1988;  Cullen et 
al.,  1990). 
Localization of dystrophin relative  to  AChR microdo- 
mains such as rows of AChR is best done by double-labeling 
using'an extracellular label on AChR. However,  the overly- 
ing basal lamina in the intact tissue impedes free access of 
Sealock et al. Dystrophin and Acelylcholine Receptor Localization  1137 Figure 5. Localization of dystrophin on Torpedo postsynaptic membranes. (A and A') Cryostat sections of perfusion-fixed electric tissue 
(N. brasiliensis) were double-labeled for immunofluoreseence with bungarotoxin/anti-toxin antibody (A) and mAb 1808 (A'). Only the 
innervated face is labeled. Invaginations  are evident in A' but not at the same positions in A (arrowheads). The noninnervated face is outlined 
by the white dashes in A. (B) Immunogold electron microscopy on fixed electric tissue (N. brasiliensis) with mAb 1958. Gold particles 
on the postsynaptic membrane occurred in clusters (small arrows) or short continuous stretches (arrowheads). A transversely sectioned 
invagination (/arge arrow) and a nerve terminal (N) are inclieated. (C-H) Postsynaptie membrane fragments from unfixed tissue (T. califor- 
nica). (C-E) mAb 1808 alone. Substructure in the labeling pattern was sometimes apparent (D, arrows), hut more homogeneous labeling 
was the rule, even when fragments were viewed en face (E). The morphology of the membrane in the gap in C (arrowhead) strongly 
suggests a domain free of AChR (criteria in Sealock, 1980).  (F-H) mAb 1808 plus buagarotoxir,/anti-toxin  antibody. The two labels were 
often precisely coextensive (arrowheads). b, basal lamina; m, bottom of the mieroculture well used for the labeling reaction. Bars; (A~ 
10 ~m; (B)  1 ~m; (C) 0.5 ~m. 
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(A-C) plus mAb 1808 (A' and B') or a mAb (mAb 1234) against the 43-kD protein (C'), then embedded in Epon and sectioned (0.2- 
0.4 #m) for microscopy. Zones labeled by mAb 1808 but not bungarotoxin (arrows in A', B') correspond to the junctional folds. Zones 
labeled by toxin/anti-toxin but not mAb 1808 (arrowheads  in A, smaller zones at various places in A and B) correspond to the AChR-rich 
crests of the junctional folds. In contrast, images given by toxin/anti-toxin and mAb 1234 were essentially identical (C and C'). Bar, 10 #m. 
conventional gold particles to the membrane (Sealock et al., 
1984).  We therefore double-labeled membrane fragments 
which had been prepared from unfixed electric tissue in the 
presence of Zn  2+ to prevent the formation of sealed vesicles 
(Sealock et al.,  1984).  The probes  were  mAb  1808  and 
alpha-bungarotoxin plus anti-toxin antibodies. Each probe 
alone labeled only the expected membrane surface, e.g., the 
intracellular labeling by mAb 1808 shown in Fig. 5, C and 
D. The intensity of labeling by mAb 1808 was higher with 
these fragments than with tissue, presumably reflecting im- 
proved access of antibody to dystrophin. Substructure in the 
labeling pattern could be found (arrows in Fig. 5 D), but so 
could zones that were nearly homogeneously labeled even 
when viewed en face (Fig. 5 E). When the membranes were 
double-labeled,  AChR  domains  were  dystrophin-positive 
(Fig.  5, F-H), and domains in which the two labels were 
coextensive were common (arrowheads). These results fur- 
ther establish that dystrophin is intimately intermingled with 
AChR in the electroplaque postsynaptic membrane, appar- 
ently at the level of AChR microdomains. 
The labeling intensities given by mAb 1808 and by toxin/ 
anti-toxin were comparable in the experiments of Fig.  5, 
C-H). However, gel electrophoresis of purified postsynaptic 
membranes shows that dystrophin molecules are far less nu- 
merous than AChR; Woodruff et al.  (1987)  estimated one 
molecule of the 300-kD protein for every 10 molecules of 
AChR on this basis. The discrepancy is explained by our ob- 
servation that with several probes for AChR (toxin/anti-toxin 
or various mAbs followed by protein A-gold or second anti- 
body gold), gold particle density saturates at or below 2,000 
particles/#m  2 for all probes (Sealock, R., unpublished re- 
sults). This compares to 8,000-10,000 molecules of AChR/ 
#m  2 (hence  16,000-20,000  toxin binding sites/t~m  ~) in re- 
gions of highest AChR density (Heuser and Salpeter,  1979; 
Bridgman et al., 1987). Because of this limitation in the im- 
munogold method, our results are strictly qualitative. 
Localization of  Dystrophin in the 
Neuromuscular Junction 
To determine whether dystrophin also occurs on AChR-rich 
domains at the neuromuscular  junction, small pieces of fixed 
rat  skeletal muscle were  subjected to  immunofluorescent 
labeling for dystrophin and AChR, embedded in Epon, sec- 
tioned at 0.2-0.4/zm thickness, and prepared for fluores- 
cence microscopy (see Materials and Methods). The result- 
ing images could be divided into three zones: (a) those that 
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anti-toxin (Fig. 6, A, A; B, B'). On the basis of the appearance 
of these zones in a large number of sections, they correspond 
to the deeper regions of the junctional folds, where AChR 
density is low (Fertuck and Salpeter,  1976). We have previ- 
ously shown by direct means that the junctional folds can be 
reliably identified in fluorescent images of this sort (Froeh- 
ner et al.,  1987).  (b) Smaller zones labeled by toxin/anti- 
toxin but not by anti-dystrophin.  These correspond to the 
receptor-rich  crests of the junctional  folds, and were best 
seen in grazing sections (arrowheads in Fig. 6 A). (c) Zones 
that contain both probes, either because AChR and dystro- 
phin were intermingled in these regions or because dystro- 
phin and AChR-rich regions were superimposed along the 
optical axis of the microscope. Corresponding results were 
obtained with mAb 1958 and Xenopus skeletal muscle (data 
not shown). In contrast, when rnAb 1808 was replaced with 
an mAb against the AChR-associated 43-kD protein (mAb 
1234; Peng and Froehner, 1985), the two images were virtu- 
ally identical  down to the finest details,  even in the most 
complicated images (Fig. 6, C and C'). From these results, 
dystrophin  is most clearly  a  component of the junctional 
folds. It may also be present on some AChR-rich regions, but 
it is not an obligatory component of regions of highest AChR 
density. 
Outside  the neuromuscular junction,  labeling  by rnAbs 
1808 and 1958 was evenly distributed along the sarcolemma; 
no periodicity  suggestive of a  relationship  to  sarcomeric 
structures could be detected. No labeling of nerve terminals, 
axons, or other nonmuscle structures could be detected. 
Localization of  Dystrophin in Cultured Muscle 
Aggregates or clusters of AChR develop on the substrate- 
attached surfaces of cultured muscle cells by processes be- 
lieved to be similar to those involved in AChR accumulation 
at developing'neuromuscular junctions  (reviewed in Bloch 
and Pumplin,  1988).  To identify the  relationship  between 
AChR and dystrophin during the clustering process, we la- 
beled cultured myotomal muscle cells from Xenopus tadpoles 
using bungarotoxin and mAb 1958 (indirect immunofluores- 
cence). At 2 d in culture,  these mononucleated,  nonfusing 
cells showed prominent AChR clusters (Fig. 7, A-C) similar 
to clusters  described previously  (Anderson  et al.,  1977). 
Anti-dystrophin staining was detectable in all muscle cells, 
but in highly variable patterns ranging from weak and diffuse 
(Fig. 7 A') to somewhat organized (Fig. 7, B' and C'). Corre- 
lations between AChR and dystrophin staining were weak at 
best (Fig.  7,  C, and C'). 
In older cultures (10-d cultures are shown), all muscle cells 
stained strongly for dystrophin, generally in a rich and highly 
variable pattern of streaks and patches (Fig. 7, D'-K'). Simi- 
lar patterns of streaks and patches have been observed in la- 
beling of cultured human muscle cells with anti-dystrophin 
antibodies  (Miranda  et al.,  1988).  Virtually  every AChR 
cluster  (Fig.  7, D-K) was a  site of prominent  dystrophin 
staining, with the distribution of dystrophin often bearing an 
obvious general relationship to the cluster as a whole. Most 
cells also had dystrophin-positive sites that were not associ- 
ated with clusters (not shown). On detailed examination at 
cluster sites, the dystrophin distribution generally appeared 
to surround  or interdigitate  with AChR-rich domains  (the 
arrows in Fig. 7 indicate corresponding points in pairs of im- 
ages). Interdigitation  is illustrated in Fig. 7, F and F'  and, 
at higher magnification,  in J  and J'.  Fig. 7, I and I'  shows 
a particularly  good example of dystrophin surrounding  an 
AChR cluster. Fig. 7, G and G' (shown at higher magnifica- 
tion in K, K') and H, H'  show intermediate  situations. 
Dystrophin could not be detected in any nonmuscle cell 
type present in these cultures (fibroblasts and melanocytes), 
as expected from the very low levels of dystrophin mRNA 
in fihroblasts (Chelly et al., 1988). Neurons were not present 
in sufficient quantity to have been examined. 
Discussion 
In this study, we have described two mAbs against distinct 
epitopes of Torpedo and muscle dystrophins and used them 
to localize dystrophin relative to AChR domains in electric 
tissue and skeletal muscle. We have also shown that Torpedo 
dystrophin is identical to the 270/300-kD protein (Woodruff 
et al., 1987; Carr et al., 1989), a fact that was originally ob- 
scured (Chang et al.,  1989; Jasmin et al.,  1990) by the low 
relative molecular mass of the latter compared with the value 
usually cited for muscle dystrophin (~,,400,000;  known mo- 
lecular weight, 427 kD). That value was determined by ex- 
trapolation from lower molecular weight standards (Hoffman 
et al., 1987). We have confirmed, however, that both dystro- 
phins migrate on our gels as though their relative molecular 
masses were ~300,000 when compared to proteins of  known, 
bracketing molecular weights.  The possibility that the low 
value in our experiments is due to proteolytic degradation is 
very unlikely, since the Torpedo and mouse muscle proteins, 
which were prepared in the presence of a cocktail of protease 
inhibitors (see Materials and Methods), would have to have 
been degraded to the same extent. In addition, Torpedo dys- 
trophin appears as a thin,  flexible rod ,,o175 nm long after 
immunoaffinity purification and rotary shadowing (Wallace, 
N.  R.,  and R.  Sealock,  unpublished  results).  This agrees 
well with the predicted shape and length (150 nm) of muscle 
dystrophin (Koenig et al.,  1988).  The deduced amino acid 
sequence of the COOH-terminal domain of the Torpedo  pro- 
tein also shows a high degree of homology to human skeletal 
muscle dystrophin (Yeadon et al.,  1991).  Thus, the identifi- 
cation of the Torpedo  protein as an authentic, full-sized dys- 
trophin is supported by a substantial body of evidence. 
The discovery of postsynaptic dystrophin  at cholinergic 
synapses (Shimizu et al.,  1989; Jasmin et al.,  1990) raised 
the possibility of a role for dystrophin in molecular organiza- 
tion of AChR, an incompletely understood process (reviewed 
in Bloch and Pumplin,  1988; Pumplin,  1989). The close in- 
termingling of Torpedo dystrophin with AChR that we have 
found in electric tissue is consistent with such a role. How- 
ever, the presence of  the AChR-specific 43-kD protein in both 
muscle and electric tissue (reviewed in Mitra et al.,  1989a 
and b) and the unequivocal demonstration  that the 43-kD 
protein can cause AChR clustering  (Froehner et al.,  1990) 
make it very likely that AChR is organized by similar mecha- 
nisms in the two tissues. It was thus surprising to find that 
dystrophin is apparently absent in regions of highest AChR 
density in the neuromuscular junction, and absent or present 
in low concentrations and poorly organized at young AChR 
clusters in Xenopus muscle.  Furthermore,  dystrophin's oc- 
currence  in  domains  that  surround  and  interdigitate  with 
AChR domains in older clusters is shared with several pro- 
The Journal  of Cell Biology,  Volume 113, 1991  1140 Figure 7. AChR clusters on cultured Xenopus muscle. Cultures were double-labeled for fluorescence with bungarotoxin (unprimed  letters) 
and mAb 1958 (primed letters). In 2-d cultures (A-C'), dystrophin was often barely detectable (right hand cluster in A and A') or organized 
with only a vague relationship to clusters (B and B'). When a relationship was evident, the dystrophin concentration was low (C and C'). 
In 10-d  cultures (D-F), the dystrophin distribution at clusters was typically broader than the AChR distribution, but usually had an obvious 
general relationship to it. Striations in the AChR cluster (F and H) were accompanied by striations in the dystrophin distribution  (F' and 
H'), with AChR domains lying between dystrophin domains; arrows in F and F' indicate corresponding positions.  Some AChR clusters 
were surrounded by dystrophin (G-f), sometimes strikingly so (I and/'). Dystrophin patches also occurred on most cells in regions devoid 
of AChR clusters (not shown). J,J': detail from F,,F'. K,K': detail from G,G'. Arrows indicate corresponding positions. Bars, A (10 ~tm) 
applies to A-I' ; J (5/Lm) applies to J-K'. 
teins such as vinculin, which can be extracted from clusters 
with little alteration of the AChR distribution (Bloch, 1984). 
Cluster-associated proteins of this type thus appear to have 
at best an indirect role in AChR organization in muscle. This 
would be consistent with the normal miniature endplate po- 
tentials, AChR distribution and AChR content in junctions 
from Duchenne patients (Sakakibara et al.,  1977). 
Since dystrophin occurs in the junctional folds, a partial, 
trivial explanation for the particularly bright staining of the 
junction in low resolution samples such as cryostat sections 
is the increased membrane area in the folds. The important 
question  of whether the density of dystrophin (molecules/ 
squared microns) on the junctional fold membrane may also 
be  increased  relative  to  the  extrajunctional  sarcolemma has 
not  been addressed directly.  Interestingly,  the  junction  also 
appeared substantially  brighter  than the  surrounding sarco- 
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with a higher density of dystrophin in the folds, but further 
interpretation would not be justified without quantitative 
measures of membrane area, the photographic intensities, 
and the dose-response characteristics of the film. 
Two possible general explanations could account for the 
apparently different localizations of dystrophin relative to 
AChR in muscle and electric tissue. One would assume a 
similar role for postsynaptic dystrophin in the two tissues. In 
the electroplaque, distinct spaces can occur between rows of 
AChR (Heuser and Salpeter, 1979; Hirokawa, 1983). If dys- 
trophin is confined to these spaces, its relationship to AChR 
would be analogous to that in AChR clusters in cultured mus- 
cle. Should mixing of dystrophin and AChR domains occur 
during preparation of membrane fragments (Fig. 5), the two 
proteins would appear intermingled. While it seems unlikely 
that such a mechanism would account for images like those 
in Fig. 5,  G-I,  it cannot be ruled out without further evi- 
dence. At the junction, on the other hand, the membrane 
proteins to which dystrophin is believed to bind (Ervasti et 
al., 1990) may be excluded from the close two-dimensional 
arrays of  AChR at the crests of  the  junctional folds (Hirokawa 
and Heuser, 1982), while remaining in the deep parts of the 
folds. 
Alternatively, dystrophin in the electroplaque could serve 
a role in AChR organization that is assumed by another pro- 
tein in muscle. At clusters, AChR domains are overlaid by 
a unique isoform of  beta-spectrin (Bloch and Morrow, 1989; 
Pumplin,  1989).  Several lines of evidence suggest that this 
spectrin has a key role in AChR anchoring, possibly acting 
in concert with actin and the 43-kD protein. A correspond- 
ing protein has not been identified in the electroplaque; spec- 
trin has thus far been found only on the nonlnnervated face 
(Kordeli et al., 1987).  However, dystrophin is homologous 
to  beta-spectrin  (the  actin-binding  subunit  of  spectrin) 
(Byers et al., 1989; Hoffman and Kunkel, 1989).  If a spec- 
trin or spectrin-like protein is essential for AChR organiza- 
tion, dystrophin potentially has the activities and localization 
for assuming such a role in the electroplaque. 
Exploration of the  second explanation will require de- 
tailed localization of the long dystrophin molecule relative 
to the characteristic rows in which AChR is organized in 
electric tissue (Heuser and Salpeter, 1979; Hirokawa, 1983). 
Our results (Fig. 5) have established that the epitope recog- 
nized by mAb 1808 can lie in AChR domains. However, we 
do not yet know where on the dystrophin molecule that epi- 
tope occurs, and if dystrophin should lie partly in and partly 
outside AChR domains, other mabs could give quite different 
results. This uncertainty is unlikely to be resolved until epi- 
topes along the full length of the dystrophin molecule can be 
localized relative to undisturbed AChR domains (rows)  or 
until dystrophin can be directly visualized along with AChR 
on the membrane surface. 
At AChR clusters in rat myotubes, AChR domains inter- 
digitate with domains of closest contact between the muscle 
cell membrane and the culture substrate (Bloch and Pump- 
lin, 1988). The dystrophin  domains in theXenopus cells (Fig. 
7) correspond to these contact domains on the basis of their 
morphology and the fact that they contain talin, a focal adhe- 
sion protein (Kramarcy and Sealock, 1990). This agrees with 
our finding that dystrophin is most reliably concentrated in 
the junctional fold region of the mature junction (Fig. 6), 
since the contact domains at clusters are believed to be ana- 
logues of the folds (Bloch and Pumplin,  1988).  A specific 
role for dystrophin in elaboration or maintenance of the folds 
could offer an explanation for the facts that in Duchenne mus- 
cle, the folds show focal degeneration with accumulation of 
excess basal lamina (Engel, 1986), and in the mdx mouse so- 
leus muscle the folds of otherwise normal appearing junc- 
tions are on average 50%  shorter than in normal muscle 
(Torres  and Duchen,  1987). 
Dystrophin is one of four cytoplasmic peripheral mem- 
brane proteins identified thus far in Torpedo postsynaptic 
membranes. Of these, only the 43-kD protein has proved to 
be specific to and associated with AChR. The remaining two 
proteins, a 58- or 51-kD protein (Froehner et al., 1987; Carr 
et al., 1989) and an 87-kD protein (Carr et al., 1989), have 
immunochemically  detectable counterparts in muscle which 
are cytoplasmic sarcolemmal proteins. These proteins share 
with  dystrophin the  interesting property  of occurring  in 
patches on the surface of immature (cultured) skeletal mus- 
cle, but spreading to the entire sarcolemma in mature mus- 
cle. In addition, the 58-kD protein and dystrophin have very 
similar distributions on the electroplaque postsynaptic mem- 
brane in in-anunogold experiments (cf. Fig. 5 and Froehner 
et al., 1987).  Like dystrophin, the muscle 58-kD protein is 
a prominent component of the myotendinous  junction (Chen 
et al., 1990) and codistributes precisely with talin outside of 
AChR clusters (Kramarcy and Sealock,  1990).  Antibodies 
against the 58-kD protein also label the sarcolemmae of rat 
cardiac muscle and chicken gizzard cells. These facts clearly 
suggest that these proteins could be part of a functional com- 
plex with dystrophin. In support of  this hypothesis, we report 
elsewhere that the 58-kD protein copurifies with Torpedo 
dystrophin and that in the absence of dystrophin (i.e.,  in 
mdx mouse muscle) its association with the sarcolemma is 
greatly reduced (Butler, M. H., K. Douville, A. A. Mur- 
nane, R. Sealock, and S. C. Froehner.  199ff J.  Cell. Biol. 
111:165a). 
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